Versigent Q3 Adjusted Earnings, Net Sales Rise; Full-Year 2026 Net Sales Guidance Narrowed

08:59 AM EST, 11/04/2026 (MT Newswires) -- Versigent (VGNT) reported Q3 adjusted earnings Wednesday of $1.91 per diluted share, up from $1.81 a year earlier. Two analysts polled by FactSet expected $1.83. Net sales for the quarter ended Sept. 30 were $2.45 billion, up from $2.29 billion a year earlier. Analysts expected revenue of $2.42 billion. The company narrowed its full-year 2026 net sales guidance to a range of $9.5 billion to $9.6 billion from the previous range of $9.4 billion to $9.6 billion. Analysts expect revenue of $9.53 billion. The company's shares were down 2% in premarket activity.